I

IMNM

IMNM

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio18% buys
BearishBullish
IMNM Live QuoteReal-time
$16.61
$1.39(-7.72%)1M
Day Range$16.45 – $17.18
Open$17.17
Previous Close$16.78
Volume881.3K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.96B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.63
Price to Book4.4
Dividend Yield0.65%
Beta (Volatility)2.66
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $16.61 (1%)
Low: $16.41High: $30.06
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$35.13-76.6% upside

Insider Buys

17

$6.05M

Insider Sales

15

$27.51M

Total Volume

$33.56M

58 transactions

Net Activity

$21.46M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
70CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 82% of total transaction value.
  • •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys26 sells

$329.12B total

B
2

Barchas Isaac

Dir

0 buys5 sells

$18.27M total

S
3

Siegall Clay B

Pres, CEO

7 buys0 sells

$4.87M total

R
4

Rosett Max

CFO

0 buys2 sells

$2.52M total

L
5

Lechleider Robert

Chief Medical Officer

1 buys2 sells

$2.49M total

Trading History
IMNM insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 11, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell59.3K$-13200.00$0

Sep 11, 2026

2 months ago

Higgins Jack

Chief Scientific Officer

C-Level
Sell13.2K$25.32$334K

Aug 10, 2026

3 months ago

Barchas Isaac

Dir

Director
Sell83.5K$26.35$2.20M

Aug 10, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell92.2K$-83464.00$0

Aug 6, 2026

3 months ago

Barchas Isaac

Dir

Director
Sell36.1K$26.06$940K

Aug 6, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell175.7K$-36088.00$0

Aug 4, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-90616.00$0

Aug 4, 2026

3 months ago

Horn Kinney

CHIEF BUSINESS OFFICER

C-Level
Sell90.6K$25.09$2.27M

Jul 7, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-1092.00$0

Jul 7, 2026

4 months ago

Horn Kinney

CHIEF BUSINESS OFFICER

C-Level
Sell1.1K$25.00$27K

Jul 6, 2026

4 months ago

Barchas Isaac

Dir

Director
Sell100.0K$24.13$2.41M

Jul 6, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell211.8K$-100000.00$0

Jul 2, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.8K$-55000.00$0

Jul 2, 2026

4 months ago

Lechleider Robert

Chief Medical Officer

C-Level
Sell55.0K$22.62$1.24M

Jun 30, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell620.3K$-201050.00$0

Jun 30, 2026

4 months ago

Barchas Isaac

Dir

Director
Sell201.1K$21.85$4.39M

Jun 25, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell15.8K$-55000.00$0

Jun 25, 2026

4 months ago

Lechleider Robert

Chief Medical Officer

C-Level
Sell55.0K$19.85$1.09M

Jun 15, 2026

5 months ago

Rosett Max

CFO

CFO
Sell60.0K$18.23$1.09M

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell54.0K$-60000.00$0

Jun 5, 2026

5 months ago

Bienaime Jean Jacques

Dir

Director
Sell10.5K$19.41$204K

Jun 5, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell43.4K$-10500.00$0

Jun 5, 2026

5 months ago

Bienaime Jean Jacques

Dir

Director
Buy10.5K$19.45$204K

May 15, 2026

6 months ago

Bienaime Jean Jacques

Dir

Director
Buy5.0K$20.70$104K

May 15, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell43.4K$5000.00$217.07M

Apr 2, 2026

7 months ago

Higgins Jack

Chief Scientific Officer

C-Level
Sell9.4K$21.64$204K

Apr 2, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell25.0K$-9438.00$0

Apr 2, 2026

7 months ago

Rosett Max

CFO

CFO
Sell65.0K$21.92$1.42M

Mar 27, 2026

7 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell690.7K$25450.00$17.58B

Mar 27, 2026

7 months ago

Siegall Clay B

Pres, CEO

CEO
Buy25.4K$19.67$501K

Mar 20, 2026

8 months ago

Wagenheim Philip

Dir

Director
Sell65.0K$20.55$1.34M

Mar 20, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell341.1K$-65000.00$0

Mar 10, 2026

8 months ago

Bienaime Jean Jacques

Dir

Director
Buy2.0K$21.84$44K

Mar 10, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell38.4K$2000.00$76.83M

Dec 30, 2025

10 months ago

Siegall Clay B

Pres, CEO

CEO
Buy4.7K$21.15$100K

Dec 30, 2025

10 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell665.3K$4729.00$3.15B

Dec 22, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell4.17M$-383200.00$0

Dec 22, 2025

11 months ago

Barchas Isaac

Dir

Director
Sell383.2K$21.74$8.33M

Dec 19, 2025

11 months ago

Siegall Clay B

Pres, CEO

CEO
Buy7.3K$20.48$149K

Dec 19, 2025

11 months ago

Tsai Philip

Chief Technical Officer

CTO
Buy10.0K$20.49$205K

Dec 19, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell660.5K$7278.00$4.81B

Dec 18, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell853.2K$46511.00$39.69B

Dec 18, 2025

11 months ago

Siegall Clay B

Pres, CEO

CEO
Buy46.5K$21.50$1000K

Jun 3, 2025

17 months ago

Bienaime Jean Jacques

Dir

Director
Buy5.0K$9.38$47K

Jun 3, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell36.4K$5000.00$182.07M

Mar 26, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell806.7K$137100.00$110.60B

Mar 25, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell31.4K$7800.00$245.04M

Mar 25, 2025

20 months ago

Bienaime Jean Jacques

Dir

Director
Buy7.8K$7.78$61K

Mar 26, 2025

20 months ago

Siegall Clay B

Pres, CEO

CEO
Buy137.1K$7.29$999K

Mar 24, 2025

20 months ago

Bienaime Jean Jacques

Dir

Director
Buy7.0K$8.21$57K

Mar 24, 2025

20 months ago

Tsai Philip

CTO

CTO
Buy12.3K$8.42$104K

Mar 24, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell23.6K$7000.00$165.31M

Jan 31, 2025

21 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell669.6K$150000.00$100.45B

Jan 31, 2025

21 months ago

Siegall Clay B

Pres, CEO

CEO
Buy150.0K$7.75$1.16M

Nov 21, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell519.6K$100000.00$51.96B

Nov 21, 2024

24 months ago

Siegall Clay B

Pres, CEO

CEO
Buy100.0K$9.62$962K

Nov 21, 2024

24 months ago

Tsai Philip

CTO

CTO
Buy21.0K$9.43$198K

Nov 21, 2024

24 months ago

Lechleider Robert

Chief Medical Officer

C-Level
Buy15.8K$9.48$150K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
IMNM Buy Conviction18%
Industry Rank#0 of 570
Volume Contribution0.2%
Total Industry Activity$16.52B

IMNM has an insider buy conviction of 18%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for IMNM

Over the last 90 days, corporate insiders at IMNM (IMNM) engaged in a total of 58 transactions reported via SEC Form 4 filings. Among these, 17 were open-market purchases and 15 were sales. The total volume of insider trading reached $33.56M.

The net insider activity for IMNM shows a net selling bias of $21.46M. This activity represents a 18% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 806.7K shares valued at $110.60B on Mar 26, 2025.

Live Market News & Developments
Aggregated real-time headlines for IMNM (IMNM)
6 updates

Immunome, Inc. (IMNM) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Immunome, Inc. (IMNM) stock price, news, quote and history

Yahoo Finance UKYesterday

Two healthcare conference talks will stream live, with replays available for about a month.

Stock Titan2d ago

IMNM - Immunome Inc Stock Price and Quote

Finviz178d ago

IMNM Forecast — Price Target — Prediction for 2027

TradingView148d ago

Immunome, Inc. (IMNM) stock price, news, quote and history

Yahoo Finance Singapore9d ago

FAQs About IMNM Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for IMNM.

Based on SEC Form 4 disclosures, the Insider Confidence Score for IMNM is currently 70/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 17 purchases and 15 sales by company executives over the last 90 days.

The CEO Conviction Index for IMNM is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.